Linola

Urea, the active ingredient in Linola, is a compound presented as a topical preparation for skin use. It helps to moisturize and soften the outer layer of the skin, supporting the management of dry and hyperkeratotic conditions. It is commonly formulated with moisturizing excipients to enhance skin hydration and improve texture.

GNH USA supplies Linola as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Urea is a topical keratolytic and humectant used in the management of disorders affecting the stratum corneum.

- Dry skin (xerosis): Increases water content in the epidermis, reducing roughness, scaling and tightness. - Ichthyosis: Softens the thickened, plate‑like scales and improves skin pliability, facilitating daily care. - Keratosis pilaris: Helps dissolve keratin plugs within hair follicles, leading to smoother skin appearance. - Hyperkeratotic eczema: Reduces excessive keratin buildup, lessening plaque thickness and associated itching.

Topical urea may cause local skin reactions, which are generally mild but can be bothersome.

Common Side Effects: - Skin irritation: mild redness or tingling at the application site. - Dryness: transient increase in skin dryness after initial use. - Itching: mild pruritus that usually resolves with continued use.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe redness, swelling, or blistering requiring medical attention. - Eczematous eruption: widespread eczema-like rash. - Hyperpigmentation: darkening of the skin in the treated area. - Ulceration: rare breakdown of skin integrity.

When using Linola, consider the following precautions to minimize adverse reactions and ensure product stability.

- Application area: Apply only to intact, non‑inflamed skin unless directed by a healthcare professional. - Concentration: Use the concentration recommended by the prescriber; higher concentrations may increase irritation risk. - Test patch: Perform a small patch test on a limited area before full application. - Occlusion: Avoid covering the treated area with airtight dressings unless advised, as this may enhance absorption and irritation. - Sun exposure: Protect treated skin from excessive sunlight, as urea can increase photosensitivity. - Store at below 25°C: Keep the product in its original container, protect from moisture and direct heat.

Topical urea has a low potential for systemic drug interactions, but certain topical agents may affect its safety or efficacy.

Major Interactions (Avoid): - Strong irritants: Concurrent use with potent topical steroids or retinoids may exacerbate skin irritation. - Acidic formulations: Combining with low‑pH products can increase discomfort and barrier disruption.

Moderate Interactions (Monitor Closely): - Occlusive dressings: May increase urea absorption, leading to heightened local effects. - Other keratolytics: Using alongside salicylic acid or glycolic acid can amplify irritation. - Antifungal creams: May alter the efficacy of both agents; monitor therapeutic response.